Morten Frier Gjerstorff (Morten Gjerstorff, Morten F Gjerstorff)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Squamous Cell Carcinoma

Positive Breast Cancer

Cancer Stem Cells

Top Venues

Molecular cancer

Proceedings of the National Academy of Sciences of the United States of America

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Sofie Traynor, Mie K Jakobsen, Tina M Green, Hana Komic, Yaseelan Palarasah, Christina B Pedersen, Henrik Jørn Ditzel, Fredrik B Thoren, Per Guldberg, Morten Frier Gjerstorff
Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. Journal for immunotherapy of cancer 12 (6) (2024)
Sofie Traynor, Mie K Jakobsen, Tina M Green, Hana Komic, Yaseelan Palarasah, Christina B Pedersen, Henrik Jørn Ditzel, Fredrik B Thoren, Per Guldberg, Morten Frier Gjerstorff
Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. Journal for immunotherapy of cancer 12 (6) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Odd L Gammelgaard, Mikkel G Terp, Christian Renn, Aran F Labrijn, Oliver Hamaker, Aaraby Yoheswaran Nielsen, Henriette Vever, Soren Wk Hansen, Morten Frier Gjerstorff, Christa Elisabeth Müller, Paul W H I Parren, Henrik Jørn Ditzel
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity. Journal for immunotherapy of cancer 10 (9) (2022)
Morten Frier Gjerstorff, Sofie Traynor, Odd L Gammelgaard, Simone Johansen, Christina B Pedersen, Henrik Jørn Ditzel, Mikkel G Terp
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer. Cancers 14 (24) (2022)
Simone Johansen, Sofie Traynor, Malene Laage Ebstrup, Mikkel Green Terp, Christina Bøg Pedersen, Henrik Jørn Ditzel, Morten Frier Gjerstorff
ZBED1 Regulates Genes Important for Multiple Biological Processes of the Placenta. Genes 13 (1) (2022)
Morten Frier Gjerstorff, Sofie Traynor, Odd L Gammelgaard, Simone Johansen, Christina B Pedersen, Henrik Jørn Ditzel, Mikkel G Terp
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer. Cancers 14 (24) (2022)
Behzad Mansoori, Mikkel Green Terp, Ali Mohammadi, Christina Bøg Pedersen, Henrik Jørn Ditzel, Behzad Baradaran, Morten Frier Gjerstorff
HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 13 (20) (2021)
Behzad Mansoori, Ali Mohammadi, Henrik Jørn Ditzel, Pascal H G Duijf, Vahid Khaze, Morten Frier Gjerstorff, Behzad Baradaran
HMGA2 as a Critical Regulator in Cancer Development. Genes 12 (2) (2021)
Aaraby Y Nielsen, Maria Ormhøj, Sofie Traynor, Morten Frier Gjerstorff
Augmenting engineered T-cell strategies in solid cancers through epigenetic priming. Cancer immunology, immunotherapy : CII 69 (11) (2020)
Simone Johansen, Morten Frier Gjerstorff
Interaction between Polycomb and SSX Proteins in Pericentromeric Heterochromatin Function and Its Implication in Cancer. Cells 9 (1) (2020)
Behzad Mansoori, Ali Mohammadi, Morten Frier Gjerstorff, Solmaz Shirjang, Zahra Asadzadeh, Vahid Khaze Shahgoli, Uffe Holmskov, Tohid Kazemi, Pascal H G Duijf, Behzad Baradaran
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancer. Journal of cellular physiology (2019)
Behzad Mansoori, Ali Mohammadi, Zahra Asadzadeh, Solmaz Shirjang, Mahsa Minouei, Fereydoon Abedi-Gaballu, Neda Shajari, Tohid Kazemi, Morten Frier Gjerstorff, Pascal H G Duijf, Behzad Baradaran
HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancy. Journal of cellular physiology 234 (10) (2019)
Nadine H Brückmann, Sofie N Bennedsen, Pascal H G Duijf, Mikkel G Terp, Mads Thomassen, Martin Larsen, Christina B Pedersen, Torben Kruse, Nicolas Alcaraz, Henrik Jørn Ditzel, Morten Frier Gjerstorff
A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence. Cell death & disease 10 (11) (2019)
Behzad Mansoori, Ali Mohammadi, Mehri Ghasabi, Solmaz Shirjang, Razeieh Dehghan, Vahid Montazeri, Uffe Holmskov, Tohid Kazemi, Pascal H G Duijf, Morten Frier Gjerstorff, Behzad Baradaran
miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. Journal of cellular physiology 234 (6) (2018)
Simone Valentin Hansen, Sofie Traynor, Henrik Jørn Ditzel, Morten Frier Gjerstorff
Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers. PloS one 13 (10) (2018)
Alexei F Kirkin, Karine N Dzhandzhugazyan, Per Guldberg, Johnny Jon Fang, Rikke Sick Andersen, Christina Dahl, Jann Mortensen, Tim Lundby, Aase Wagner, Ian Law, Helle Broholm, Line Madsen, Christer Lundell-Ek, Morten Frier Gjerstorff, Henrik Jørn Ditzel, Martin R Jensen, Walter Fischer
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells. Nature communications 9 (1) (2018)